Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 81,599 | 112,435 | 157,865 | 51,105 | 114,378 |
| Gross Profit | 81,599 | 112,435 | 157,865 | 51,105 | 114,378 |
| Operating Expenses | 59,978 | 58,935 | 48,839 | 41,894 | 35,042 |
| Operating Income | 21,621 | 53,500 | 109,026 | 9,211 | 79,336 |
| Interest Expense | 0 | 11,306 | 21,625 | 10,350 | 21,516 |
| Other Income | 32,063 | 0 | 14,560 | 0 | 0 |
| Pre-tax Income | 53,684 | 42,194 | 101,961 | -1,139 | 57,820 |
| Income Tax | 11,974 | 9,409 | -18,813 | -241 | 12,376 |
| Net Income Continuous | 41,710 | 32,785 | 120,774 | -898 | 45,445 |
| Net Income | $41,710 | $32,785 | $120,774 | $-898 | $45,445 |
| EPS Basic Total Ops | 0.68 | 0.54 | 1.98 | -0.01 | 0.75 |
| EPS Basic Continuous Ops | 0.68 | 0.54 | 1.63 | -0.01 | 0.75 |
| EPS Diluted Total Ops | 0.67 | 0.53 | 1.95 | -0.01 | 0.73 |
| EPS Diluted Continuous Ops | 0.67 | 0.53 | 1.61 | -0.01 | 0.73 |
| EBITDA(a) | $21,621 | $53,500 | $109,026 | $9,211 | $79,336 |